Lorna has 14 years’ experience in the cardiovascular field across biotech and academic sectors. She joined Oxstem in 2017 as a senior scientist before joining the executive team in September 2019.
Lorna previously worked in the biotechnology sector and held a research fellow and project lead position at the Duke-National University of Singapore Medical School, investigating the molecular mechanisms underlying heart failure. She also worked for five years at Imperial College London developing cardioprotective small molecules where she led the biology team, working closely with internal and external industry partners. Her work was featured in FierceBiotech and is published in Cell Stem Cell (Fiedler et al., 2019).
Lorna holds a Ph.D. in vascular biology from Cardiff University and is a qualified Prince2 Practitioner.